This site is intended for US residents 18 years of age and older

INDICATIONS AND USAGE

SPRYCEL® (dasatinib) is a prescription medicine used to treat:

  • adults with newly diagnosed Philadelphia chromosome–positive (Ph+) chronic myeloid leukemia (CML) in chronic phase
  • adults with Ph+ CML who no longer benefit from, or did not tolerate, other treatment, including imatinib
  • adults with Ph+ acute lymphoblastic leukemia (Ph+ ALL) who no longer benefit from, or did not tolerate, other treatment
  • children 1 year of age and older with Ph+ CML in chronic phase
  • children 1 year of age and older with newly diagnosed Ph+ ALL in combination with chemotherapy

It is not known if SPRYCEL is safe and effective in children under 1 year of age.

Lee’s Story

Lee is a husband and father living with CML. Although learning that he had the disease was the "day the world stopped," Lee was relieved to learn that there was a medicine he could take every day in the form of SPRYCEL.

Watch

Tom’s Story

The Ph+ CML diagnosis was devastating for Tom. But after being placed on SPRYCEL, he felt he regained hope and control over his life.

Watch

Sam’s Story

Sam leaned on the support of his wife and oncologist when diagnosed with Ph+ CML.

Watch

Tiffany’s Story

Tiffany was just a child when she was diagnosed with pediatric CML. She shares her journey with SPRYCEL.

Watch

Sam’s Story: Working With Your Healthcare Team

Listen to Sam share how he partners with his healthcare team to support his journey.

Watch

Tiffany’s Story: Working With Your Healthcare Team

Listen to Tiffany share how she partners with her healthcare team to support her journey

Watch

These are actual Ph+ CML patients taking SPRYCEL. They were compensated by Bristol Myers Squibb for their participation in these videos. Your experience and results may vary.

BECOME AN INSPIRATION

“I look forward to another day just like today. SPRYCEL has given me that opportunity.”
—Lee, SPRYCEL patient

Lee, a SPRYCEL® (dasatinib) patient, standing with their arms crossed
Lee, a SPRYCEL® (dasatinib) patient, standing with their arms crossed
Back
to Top